TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. Co. is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening.

TGTX — Key Stats (updated Tuesday, July 1, 10:19 AM)

Company Name:  TG Therapeutics Inc Website:  www.tgtherapeutics.com Sector:  Drugs & Pharmaceuticals Number of ETFs Holding TGTX:  102

ETFs Holding TGTX

ETF   TGTX Weight   TGTX Amount   AVIE   %   $           IWMW   %   $           ITDD   %   $           SCDS   %   $           EAOR   %   $           AOR   %   $           XJR   %   $           VTWG   %   $           UWM   %   $           EHLS   %   $          List of all 102 ETFs holding TGTX »

TGTX — News

Featured Slideshows

10 ETFs With Stocks That Insiders Are Buying 10 ETFs With Most Upside To Analyst Targets 25 Dividend Giants Widely Held By ETFs 25 S.A.F.E. Dividend Stocks Increasing Payments For Decades Broker Darlings: Top 15 Analyst Picks of the Dow Top 25 Broker Analyst Picks of the S&P 500 Forgotten S&P 500 Giants: Analysts' Current Least Favorites 25 Top Ranked Socially Responsible Dividend Stocks 10 Oversold ETFs The Top 10 DividendRank'ed Stocks Warren Buffett Dividend Stocks The DividendRank Top 25 The Top 10 DividendRank'ed DJIA Components The Top 10 DividendRank'ed Dow Transports Components The Top 10 DividendRank'ed Dow Utilities Components The Top 10 DividendRank'ed Nasdaq 100 Components 10 Stocks Going Ex-Dividend 10 Oversold Dividend Stocks 10 Stocks Where Yields Got More Juicy 10 Dividend Bargains You Can Buy Cheaper Than Insiders Did Top Ranked Dividend Stocks With Insider Buying 10 Energy Stocks You Can Buy Cheaper Than Insiders Did 10 Metals Stocks You Can Buy Cheaper Than Insiders Did 10 Oversold Metals Stocks 10 Must-Know High-Yield REITs 10 Top DividendRank'ed Financials 10 Top DividendRank'ed Metals Stocks 10 Oversold Energy Stocks 10 Top DividendRank'ed Energy Stocks 10 Top DividendRank'ed Utility Stocks 10 Stocks Crossing Below Book Value 10 Stocks Crossing Above Their 200 Day Moving Average 10 Stocks Crossing Below Their 200 Day Moving Average 10 ETFs Crossing Above Their 200 DMA Covered Call ETF Leaders The 10 Biggest ETFs The 10 Best ETF Performers Best Vanguard ETFs By TTM Performance Worst Vanguard ETFs By TTM Performance Best iShares ETFs By TTM Performance Worst iShares ETFs By TTM Performance The 10 Worst ETF Performers 10 ETFs With Notable Inflows 10 ETFs With Notable Outflows Top 10 Analyst Rated Consumer Stocks Top 10 Analyst Rated Dividend Stocks Top 10 Analyst Rated Energy Stocks Top 10 Analyst Rated Financial Stocks Top 10 Analyst Rated Healthcare Stocks Top 10 Analyst Rated REIT Stocks Top 10 Analyst Rated Technology Stocks Best Dividend Stocks 2005-2025 Best High Dividend Stocks 2005-2025 Top Dividend Stocks 2015-2025 Best High Yield Stocks 2015-2025 Top Dividend Stocks 2020-2025 Top High Dividend Yield Stocks 2020-2025 The Top 10 DividendRank'ed Canadian Stocks The DividendRank Canada Top 25 10 Canadian Stocks Going Ex-Dividend 10 Oversold Canadian Stocks 10 Canadian Stocks Where Yields Got More Juicy 10 Must-Know High-Yield Canadian Real Estate Stocks 10 Top DividendRank'ed Canadian Financials 10 Must-Know High-Yield Canadian Energy Stocks 10 Canadian Stocks Crossing Below Book Value 10 Canadian Stocks Crossing Above Their 200 Day Moving Avg 10 Canadian Stocks Crossing Below Their 200 Day Moving Avg Stock market game

Featured News Links

• Press releases from ACCESS Newswire  • Contrarian Outlook  • Cash In on AI: Meet the Secret Stock Growing Its Dividend 212%  • A 4.2% “Big Beautiful” Dividend Set to Soar  • These 6% Tax-Free Dividends Are Languishing (for Now). Here’s When to Strike